Massive study tracks COVID-19 vaccine safety for 6,000 pregnant women and their babies
NCT ID NCT04705116
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study follows 6,000 pregnant women worldwide to compare health outcomes for those who received a COVID-19 vaccine during pregnancy versus those who did not. Researchers will track pregnancy complications, newborn health, and infant development up to 12 months old. The goal is to gather real-world data on vaccine safety, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pregistry
Los Angeles, California, 90045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Massive study tracks how lockdowns shaped mental health across america
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19
- Experimental drug aims to tame severe COVID-19 inflammation
- Malaria drug combo shows promise against COVID-19 in early trial